Novo Nordisk’s head of U.S. marketing, Ulrich Otte, is no longer in the role and is exploring other internal opportunities at the company outside of the U.S.

Hims & Hers Health is upgraded to a speculative Buy after a 20% drop, with growth potential in GLP-1 sales outweighing key ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Detailed price information for Array Technologies Inc (ARRY-Q) from The Globe and Mail including charting and trades.

Lyft (LYFT) reported $1.59 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 10.6 ...

For the quarter ended June 2025, Ormat Technologies (ORA) reported revenue of $234.02 million, up 9.9% over the same period ...

The telehealth and wellness stock tanked more than 12% Aug. 5, a day after posting mixed Q2 earnings. More importantly, Bank ...

Hims & Hers Health showed a sharper-than-expected revenue hiccup in Q2, sending the stock down. Click here to find out why ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Detailed price information for Oscar Health Inc Cl A (OSCR-N) from The Globe and Mail including charting and trades.

Healthcare tech company Privia Health Group (NASDAQ:PRVA) will be reporting results this Thursday before the bell. Here’s ...